In mice, Kiras mutations are found in over 90% ofspontaneous and chemically induced lung tumors [6].Overexpression of the cmyc gene is also frequently observed in NSCLC, butappears to be more prevalent in SCLC [7]. Here, KRAS is linked to non-small cell lung carcinoma.